Tag: Vaccines
FDA May Allow Pfizer Boosters for 12- to 15-Year-Olds by Monday
Agency also expected to reduce the amount of time adolescents and adults must wait between their second dose of vaccine and booster
No Effect on Ovarian Reserve Seen After mRNA COVID-19 Vaccination
Mean levels of anti-Müllerian hormone unchanged from baseline to three months after vaccination among reproductive-aged women
Vaccinated Kidney Transplant Recipients Vulnerable to SARS-CoV-2 Variants
After two-dose vaccination, only 64 and 67 percent of kidney transplant recipients showed neutralization against B.1.351 (β) and B.1.617.2 (δ)
Breakthrough COVID-19 Infection Risk Higher With Immune Dysfunction
Risk for breakthrough infection higher for those with immunocompromising conditions, such as HIV, rheumatoid arthritis, solid organ transplant
Cancer Patients With Breakthrough COVID-19 Remain at Risk for Severe Outcomes
No significant difference observed in 30-day mortality for fully vaccinated versus unvaccinated cancer patients with COVID-19
NVX-CoV2373 Vaccine Protects Against COVID-19
Study conducted in the U.S. and Mexico shows vaccine 90 percent effective overall, 100 percent effective against moderate-to-severe disease
mRNA COVID-19 Vaccine Less Protective in Elderly With Comorbidity
At ≥7 days after second dose, effectiveness of mRNA COVID-19 vaccine was 69 percent against infection, 86 percent against related death
Physician’s Briefing Weekly Coronavirus Roundup
COVID-19 Certification Mandates May Increase Vaccine Uptake
Country-specific information, such as prior vaccination uptake, vaccine hesitancy may influence the effect of COVID-19 certification mandates
U.S. Army Reports Progress on COVID-19 Vaccine That Fights All Variants
Animal studies have already shown new vaccine induces highly potent antibody responses against major variants